Compound: SGC0946

Drug Target: DOT1L

Drug Target pathway: Chromatin histone methylation

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences


Tissue specific analysis

AUCAUC

Statistics

All cell lines
Number of cell lines
Pearson correlation
Spearman correlation

Chart settings

Colour dots by:


Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.